ARQT

NASDAQ · Biotechnology

Arcutis Biotherapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$21.17

+0.51 (+2.47%)

As of May 9, 1:24 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +305.2% upside

Low Target $74.20

Average Target $85.78

High Target $112.10

Current Price $21.17

Current
$21.17

Target
$85.78

$74.20 $85.78 avg $112.10

Scenario Analysis

Bear Case

$74.20

250.5%

Low target

Base Case

$85.78

+305.2%

Avg target

Bull Case

$112.10

+429.5%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$31.77

-33.4% from high

52-Week Low

$12.42

+70.5% from low

50-Day SMA

$27.64

-23.4% vs SMA

200-Day SMA

$20.38

+3.9% vs SMA

RSI (14)

67.5

Neutral

Target vs 52W High

$85.78

+170.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	72%	$257.58	+27.8%
AMGN Amgen Inc	Hold	43	49%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	26	96%	$143.40	+41.5%